货号:A105790
同义名:
GSK269962 hydrochloride; GSK269962B
GSK269962A HCl是一种选择性的 ROCK(Rho 相关蛋白激酶)抑制剂,对 ROCK1 和 ROCK2 的 IC50 值分别为 1.6 nM 和 4 nM。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | ROCK ↓ ↑ | ROCK1 ↓ ↑ | ROCK2 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thiazovivin |
+
ROCK, IC50: ~0.5 μM |
98% | |||||||||||||||||
| Netarsudil HCl |
++++
ROCK, Ki: 2 nM |
99%+ | |||||||||||||||||
| Y-33075 2HCl |
++++
ROCK, IC50: 3.6 nM |
99%+ | |||||||||||||||||
| ROCK1-IN-1 |
++
ROCK, Ki: 17nM |
95% | |||||||||||||||||
| GSK429286A |
+++
ROCK1, IC50: 14 nM |
++
ROCK2, IC50: 63 nM |
99%+ | ||||||||||||||||
| Ripasudil |
++
ROCK1, IC50: 51 nM |
++
ROCK2, IC50: 19 nM |
99%+ | ||||||||||||||||
| Belumosudil |
++
ROCK2, IC50: 60 nM ROCK2, Ki: 41 nM |
99%+ | |||||||||||||||||
| Y-27632 2HCl |
++
ROCK1, Ki: 140 nM |
+
ROCK2, Ki: 300 nM |
99%+ | ||||||||||||||||
| Fasudil HCl |
+
ROCK2, Ki: 330 nM |
PKG,Rho | 98% | ||||||||||||||||
| Chroman 1 |
++++
ROCK1, IC50: 52 pM |
++++
ROCK2, IC50: 1 pM |
99% | ||||||||||||||||
| BAY-549 |
++++
ROCK1, IC50: 0.6 nM |
++++
ROCK2, IC50: 1.1 nM |
99%+ | ||||||||||||||||
| AT13148 |
+++
ROCK1, IC50: 6 nM |
+++
ROCK2, IC50: 4 nM |
PKA | 95% | |||||||||||||||
| RKI-1447 |
+++
ROCK1, IC50: 14.5 nM |
+++
ROCK2, IC50: 6.2 nM |
99%+ | ||||||||||||||||
| Hydroxyfasudil HCl |
+
ROCK1, IC50: 0.73 μM |
+
ROCK2, IC50: 0.72 μM |
PKA | 98% | |||||||||||||||
| H-1152 2HCl |
+++
ROCK2, IC50: 0.0120 μM |
PKG | 99% | ||||||||||||||||
| GSK269962A HCl |
++++
ROCK1, IC50: 1.6 nM |
+++
ROCK2, IC50: 4 nM |
99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | GSK269962A (GSK 269962) is a potent ROCK inhibitor, which effective against both ROCK1 and ROCK2 isoforms, with IC50 values of 1.6 and 4 nM, respectively. GSK269962A has anti-inflammatory and vasodilatory activities[1]. |
| 体内研究 | GSK269962A, administered via oral gavage at doses of 0.3, 1, and 3 mg/kg, leads to a dose-dependent and significant reduction in blood pressure in spontaneously hypertensive rats (SHR), indicating its potential in managing hypertension[1]. |
| 体外研究 | GSK269962A induces vasorelaxation in preconstricted rat aorta with an IC50 of 35 nM[1]. |
| Concentration | Treated Time | Description | References | |
| OCI-AML3 | 80 nM | 72 hours | Inhibited AML cell growth, induced G2 phase arrest and apoptosis | Front Pharmacol. 2022 Dec 6;13:1064470. |
| MV4-11 | 80 nM | 72 hours | Inhibited AML cell growth, induced G2 phase arrest and apoptosis | Front Pharmacol. 2022 Dec 6;13:1064470. |
| LepR+ MSCs | 1 μM | 48 hours | Inhibition of ROCK1 signaling pathway, reducing the expression of fibrosis markers Col1a1, vimentin, and α-SMA | Cell Commun Signal. 2024 May 6;22(1):257. |
| UACC62 | 625nM | 48 hours | To evaluate the effect of GSK269962A on the proliferation of MAPKi-resistant melanoma cells, showing complete inhibition of proliferation at 625nM concentration. | bioRxiv [Preprint]. 2024 Jan 11:2024.01.09.574940. |
| M481 | 625nM | 48 hours | To evaluate the effect of GSK269962A on the proliferation of MAPKi-resistant melanoma cells, showing complete inhibition of proliferation at 625nM concentration. | bioRxiv [Preprint]. 2024 Jan 11:2024.01.09.574940. |
| A375 | 625nM | 48 hours | To evaluate the effect of GSK269962A on the proliferation of MAPKi-resistant melanoma cells, showing complete inhibition of proliferation at 625nM concentration. | bioRxiv [Preprint]. 2024 Jan 11:2024.01.09.574940. |
| Administration | Dosage | Frequency | Description | References | ||
| NOD-SCID/IL2Rgnull mice | AML model | Intraperitoneal injection | 5 mg/kg and 10 mg/kg | 5 days per week for 4 weeks | Significantly prolonged mouse survival and reduced leukemia cell infiltration | Front Pharmacol. 2022 Dec 6;13:1064470. |
| Mice | PE-induced prostatic hyperplasia model | Intraperitoneal injection | 5 mg/kg | Four times a week for four weeks | GSK269962A reduces prostatic stromal hyperplasia and collagen deposition by inhibiting ROCK1 signaling pathway | Cell Commun Signal. 2024 May 6;22(1):257. |
| Dose | Rat: 30 mg/kg[2] (i.v.); 1 mg/kg- 30 mg/kg[3] (p.o.); 5 mg/kg, 10 mg/kg[4] (intra-arterially) |
| Administration | i.v., p.o., intra-arterially |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.65mL 0.33mL 0.16mL |
8.24mL 1.65mL 0.82mL |
16.47mL 3.29mL 1.65mL |
|
| CAS号 | 2095432-71-4 |
| 分子式 | C29H31ClN8O5 |
| 分子量 | 607.06 |
| SMILES Code | O=C(NC1=CC=CC(OC2=CC3=C(N=C(C4=NON=C4N)N3CC)C=N2)=C1)C5=CC=C(OCCN6CCOCC6)C=C5.[H]Cl |
| MDL No. | MFCD31536773 |
| 别名 | GSK269962 hydrochloride; GSK269962B; GSK269962; GSK269962A hydrochloride; GSK 269962 hydrochloride |
| 运输 | 蓝冰 |
| InChI Key | UYKVMFKKKLLDGL-UHFFFAOYSA-N |
| Pubchem ID | 57398146 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
沪公网安备 31011702889066号
沪ICP备2024050318号-1